Company Search:
Advanced Search
Sponsored Links
Chiome Bioscience Inc Company Snapshot
Chiome Bioscience Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chiome Bioscience Inc with three other companies in this sector in Japan: DNA Chip Research, Inc. (2016 sales of 284.16 million Japanese Yen [US$2.55 million] ), Onco Therapy Science, Inc (266.90 million Japanese Yen [US$2.40 million] of which 100% was Research & Development In Medical), and Nanocarrier Company Limited (243.34 million Japanese Yen [US$2.19 million] of which 100% was Research and Development).

Sales Analysis. During the year ended December of 2016, sales at Chiome Bioscience Inc were ¥252.22 million (US$2.27 million). This is a decrease of 10.0% versus 2015, when the company's sales were ¥280.11 million. Contributing to the drop in overall sales was the 88.9% decline in Medicine Alliance Business, from ¥248.04 million to ¥27.41 million. . However, these declines were partially offset by the increase in sales of Base Plate Technolgy License Business (up 600.9% to ¥224.80 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Chiome Bioscience Inc
  Stock Performance Chart for Chiome Bioscience Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 398.00
(Figures in Japanese Yen)
1 Week 1.3%   13 Weeks 16.4%  
4 Weeks 6.7%   52 Weeks -9.3%  
Chiome Bioscience Inc Key Data:
  Ticker: 4583 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 252,215,000
(Year Ending Jan 2017).
Employees: 42
  Currency: Japanese Yen Market Cap: 10,658,978,892
  Fiscal Yr Ends: December Shares Outstanding: 26,781,354
  Share Type: Ordinary Closely Held Shares: 3,541,100
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.